the results shown that enlargement of granules also
reduced the tabletability after the granulation process
(Sun et al.2006). Therefore, granules size
enlargement plays an important role in causing the
reduced tabletability and this become one of the major
disadvantages of roller compaction through dry
granulation.
Table 1: Levels of variables for measuring the influence of particle size in the designed experiments.
Level -1 -0.33 0 +0.33 +1
MCC (μm)
21 - 56 - 106
Theo (μm)
7 - - - 110
Fraction (%)
25 41.67 50 58.33 75
Porosity (%) 20 26.67 30 33.33 40
Other disadvantages including the process is too
slow compare with direct compression. Direct
compression has the same characteristic as an absence
of liquid binder within the process. However, dry
granulation has additional steps of transforming the
raw materials into granules by go through the
compactor. The machine would cost more money and
time which is a burden for some drug industries.
5 CONCLUSIONS
In conclusion, the dry granulation technique has
drawn the attention of many pharmaceutical
industries because of the advantages of dry
granulation by roller compaction compared with other
compaction technology. The agglomeration step of
drug formulation briefly illustrates how powder of
APIs and excipients pass through the compactor and
result in dried granules. During the dry granulation,
the absence of liquid content gives a major advantage
to this process which becomes suitable for heat and
moisture products. Dry granulation also prevents
particle segregation and contributes to flowability.
Although the dry granulation process may lose
tabletability, researchers still believe the process has
the potentials to overcome the disadvantages.
ACKNOWLEDGEMENTS
I am very grateful to the Prof. Axel for his enormous
contribution towards the project. Professor Axel
provided me with encouragement and patience
throughout the duration of this research project.
Thanks to the teacher assistant Ben Wei who always
solve my question in patience.
REFERENCES
Anshul Gupte, et al. Comparative binder efficiency
modeling of dry granulation binders using roller
compaction. Drug Development and Industrial
Pharmacy, vol 43, no. 4, pp. 574-583, 2017.
Heiman, Johanna, et al. Roller Compaction of Hydrophilic
Extended Release Tablets—Combined Effects of
Processing Variables and Drug/Matrix Former Particle
Size. AAPS PharmSciTech, vol. 16, no. 2, pp. 267–77,
2015.
Hudon, Sophie, et al. Evaluation of a Dry Coating
Technology as a Substitute for Roller Compaction for
Dry Agglomeration Applications in the Pharmaceutical
Industry. Journal of Pharmaceutical Innovation, vol. 14,
no. 3, pp. 286–303, 2019.
Michael G. Herting, Peter Kleinebudde. Roll
compaction/dry granulation: Effect of raw material
particle size on granule and tablet properties.
International Journal of Pharmaceutics, vol. 338, pp.
110-108, 2007.
Peter, Stefanie, et al. Roller compaction/Dry Granulation:
Use of the Thin Layer Model for Predicting Densities
and Forces During Roller Compaction. Powder
Technology, vol. 199, no. 2, pp. 165–75, April 2010.
Pietsch, Wolfgang. Agglomeration Processes: Phenomena,
Technologies, Equipment / Wolfgang Pietsch.
Weinheim: Wiley-VCH, 2002.
Rana, Khokra, et al. Overview on roll compaction/dry
granulation process. Pharmacologyonline, vol. 3, pp.
286-298, November 2011.
Teng, Yue, et al. Systematical Approach of Formulation
and Process Development Using Roller Compaction.
European Journal of Pharmaceutics and
Biopharmaceutics, vol. 73, no. 2, pp. 219–29, 2009.
Sun C., Calvin. On the Mechanism of Reduced
Tabletability of Granules Prepared by Roller
Compaction. International Journal of Pharmaceutics,
vol. 347, no. 1, pp. 171–72, 2008.
Stutzman, Todd., Roller Compaction: New Trends,
Challenges and Solutions: When Developing a Tablet
or Capsule, Three Widely Used Technologies Are